Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300

Cell

Volumn 93, Issue 3, 1998, Pages 361-372

  Yao, Tso Pang ^a   Oh, Suk P ^b   Fuchs, Miriam ^a   Zhou, Nai Dong ^a   Ch'ng, Lian Ee ^a   Newsome, David ^a   Bronson, Roderick T ^c   Li, En ^b   Livingston, David M ^a   Eckner, Richard ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHROMOSOME INACTIVATION; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; GENE DISRUPTION; GENE DOSAGE; GENE MUTATION; HEART DEVELOPMENT; HETEROZYGOSITY; MOUSE; NEURULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA;

EID: 17644445419     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81165-4     Document Type: Article

References (56)

1. Akimaru, H., Hou, D., and Ishii, S. (1997). Drosophila CBP is required for dorsal-dependent twist gene expression. Nat. Genet. 17, 211-214.
2. Arany, Z., Sellers, W.R., Livingston, D.M., and Eckner, R. (1994). E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77, 799-800.
3. Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., and Kelly, K. (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184.
4. Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643.
5. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
6. Borrow, J., Stanton, V.J., Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., Civin, C.I., Disteche, C., Dube, I., Frischauf, A.M., et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14, 33-41.
7. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
8. Chen, Z.F., and Behringer, R.R. (1995). twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9, 686-699.
9. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
10. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein. Nature 365, 855-859.
11. Clarke, A.R., Maandag, E.R., Roon, M.V., Lugt, N., Valk, M., Hooper, M.L., Berns, A., and Riele, H.T. (1992). Requirement for a functional RB-1 gene in murine development. Nature 359, 328-330.
12. Dillon, N., and Grosveld, F. (1993). Transcriptional regulation of multigene loci: multilevel control. Trends Genet. 9, 134-137.
13. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning and functional analysis of the adenovirus E1A-associated 300-KD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 7, 869-884.
14. Eckner, R., Yao, T.P., Oldread, E., and Livingston, D.M. (1996a). Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev 10, 2478-2490.
15. Eckner, R., Ludlow, J.W., Lill, N.L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J.A., Livingston, D.M., and Morgan, J.A. (1996b). Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16, 3454-3464.
16. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767-774.
17. Ferrara, N., Carver, M.K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell, B.L., Hillan, K.J., and Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
18. Forman, B.M., Umesono, K., Chen, J., and Evans, R.M. (1995). Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81, 541-550.
19. Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, S., Shi, Y., and Collins, T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94, 2927-2932.
20. Grunstein, M. (1997).Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
21. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
22. Gu, W., Shi, X.L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
23. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93, 11540-11545.
24. Hasegawa, K., Meyers, M.B., and Kitsis, R.N. (1997). Transcriptional coactivator p300 stimulates cell type-specific gene expression in cardiac myocytes. J. Biol. Chem. 272, 20049-20054.
25. Howe, J.A., Mymryk, J.S., Egan, C., Branton, P.E., and Bayley, S.T. (1990). Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc. Natl. Acad. Sci. USA 87, 5883-5887.
26. Ida, K., Kitabayashi, I., Taki, T., Taniwaki, M., Noro, K., Yamamoto, M., Ohki, M., and Hayashi, Y. (1997). Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22). Blood 90, 4699-4704.
27. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S., Heyman, R.A., Rose, D.W., Glass, C.K., and Rosenfeld, M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
28. Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
29. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827.
30. Lin, Q., Schwarz, J., Bucana, C., and Olson, E.N. (1997). Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407.
31. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
32. Millauer, B., Wizigmann-Voss, S., Schnürch, H., Martinez, R., Møller, N.P.H., Risau, W., and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
33. Molkentin, J.D., Black, B.L., Martin, J.F., and Olson, E.N. (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
34. Moran, E. (1993). DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
35. Nakajima, T., Uchida, C., Anderson, S.F., Lee, C.G., Hurwitz, J., Parvin, J.D., and Montminy, M. (1997a). RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90, 1107-1112.
36. Nakajima, T., Uchida, C., Anderson, S.F., Parvin, J.D., and Montminy, M. (1997b). Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11, 738-747.
37. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B., and Cech, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human [see comments]. Science 277, 955-959.
38. Nevins, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
39. Oelgeschlager, M., Janknecht, R., Krieg, J., Schreek, S., and Luscher, B. (1996). Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J. 15, 2771-2780.
40. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
41. Parker, D., Ferreri, K., Nakajima, T., LaMorte, V.J., Evans, R., Koerber, S.C., Hoeger, C., and Montminy, M.R. (1996). Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol. Cell. Biol. 16, 694-703.
42. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H., and Nabel, G.J. (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527.
43. Petrij, F., Giles, R.H., Dauwerse, H.G., Saris, J.J., Hennekam, R.C., Masuno, M., Tommerup, N., van Ommen, O.G., Goodman, R.H., Peters, D.J., et al. (1995). Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351.
44. Puri, P.L., Avantaggiati, M.L., Balsano, C., Sang, N., Graessmann, A., Giordano, A., and Levrero, M. (1997). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. Embo J 16, 369-83.
45. Sartorelli, V., Huang, J., Hamamori, Y., and Kedes, L. (1997). Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17, 1010-1026.
46. Schorle, H., Meier, P., Buchert, M., Jaenisch, R., and Mitchell, P.J. (1996). Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235-238.
47. Schule, R., and Evans, R.M. (1991). Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet. 7, 377-381.
48. Shikama, N., Lyon, L., and La Thangue, N.B. (1997). The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7, 230-236.
49. Smith, C.L., Onate, S.A., Tsai, M.J., and O'Malley, B.W. (1996). CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888.
50. Sobulo, O.M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N.A., Rowley, J.D., and Zeleznik, L.N. (1997). MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemiawith at(11;16)(q23;p13.3). Proc. Natl. Acad. Sci. USA 94, 8732-8737.
51. Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., and Ishii, S. (1997). Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc. Natl. Acad. Sci. USA 94, 10215-10220.
52. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K., and Rosenfeld, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
53. Wade, P.A., Pruss, D., and Wolffe, A.P. (1997). Histone acetylation: chromatin in action. Trends Biochem. Sci. 22, 128-132.
54. Whyte, P., Williamson, N.M., and Harlow, E. (1989). Cellular targets for transformation by the adenovirus E1A. Cell 56, 67-75.
55. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
56. Yao, T.P., Ku, G., Zhou, N., Scully, R., and Livingston, D.M. (1996). The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626-10631.